Kazia Therapeutics Limited

Entity > Corporation > US > New York City New York > Kazia Therapeutics Limited

About Kazia Therapeutics Limited

Kazia Therapeutics Limited is an oncology-focused biotechnology company developing innovative anti-cancer drugs. Kazia Therapeutics Limited collaborates with leading scientists, clinicians and investors around the world.

Kazia Therapeutics Limited Welcomes Opportunities to Potential In-licensing of Development Candidates for Oncology Indications: Our primary focus is on small molecule therapies, with a preference for those that can be orally administered and handled under controlled ambient conditions. Kazia Therapeutics Limited are able to work in all cancer types, but with a focus on solid tumour indications. Kazia Therapeutics Limited are excited about development candidates with first-in-class or best-in-class potential, where there is clear target validation, compelling proof of concept in vivo, a mature GMP manufacturing process, and availability of some GLP toxicology data.

Kazia Therapeutics Limited’s Founding And Headquarters: Kazia Therapeutics Limited was founded in 1994 by Graham Kelly. Kazia Therapeutics Limited is currently headquartered in Hornsby, New South Wales, Australia.

Industry: Business & Industrial > Pharmaceuticals & Biotech

More information about Kazia Therapeutics Limited

Company Attribute Value
Address StreetAddress: 300 Barangaroo Ave L 24, AddressLocality: Sydney, AddressRegion: New South Wales, PostalCode: 2000, AddressCountry: Australia
Founding Date 1992
Name Kazia Therapeutics Limited
Number Of Employees 8
Revenue $10,550,000 USD
Ticker Symbol NASDAQ: KZIA
Url kaziatherapeutics
Facebook facebook
Linkedin linkedin
Twitter twitter
Google google

Kazia Therapeutics Limited

us

New York City, US
18 Jun 2024

New York City, US
18 Jun 2024

Kazia Therapeutics Limited

All
News
Images
Maps
Videos
More
Page: 1 Desktop | Laptop Devices

https://www.kaziatherapeutics.com/
Kazia Therapeutics Limited
Kazia is an Australian oncology company developing innovative, high-impact drugs for cancer. Our lead program is paxalisib, which is being developed to ...
https://finance.yahoo.com › quote › KZIA
Kazia Therapeutics Limited (KZIA) Stock Price, News, ...
Kazia Therapeutics Limited operates as a biotechnology company, develops anti-cancer drugs. Its lead development candidate is Paxalisib, a small molecule, ...
https://www.bloomberg.com › company › NRT:AU
Kazia Therapeutics Ltd - Company Profile and News
Kazia Therapeutics Limited operates as an biotechnology company. The Company develops anti-cancer drugs, as well as provides pharmaceutical research and ...
https://www.prnewswire.com › news-releases › kazia-ther...
Kazia Therapeutics Announces Closing of $2 Million ...
Dec 5, 2023 — Kazia Therapeutics Limited (NASDAQ: KZIA), a biotechnology company specialising in oncology, is pleased to announce that it has entered into an.
https://www.nasdaq.com › Market Activity › Stocks
KZIA
Discover real-time Kazia Therapeutics Limited American Depositary Shares (KZIA) stock prices, quotes, historical data, news, and Insights for informed ...
https://www.annualreports.com › Company › kazia-ther...
Kazia Therapeutics Limited - AnnualReports.com
Kazia Therapeutics Limited (ASX: KZA, NASDAQ: KZIA) is an innovative oncology-focused biotechnology company, based in Sydney, Australia.
https://www.google.com › quote › KZIA:NASDAQ
Kazia Therapeutics Ltd (KZIA) Price & News - Finance
Get the latest Kazia Therapeutics Ltd (KZIA) real-time quote, historical ... Genetic Technologies Limited. $1.82. GENE 1.09%. Alterity Therapeutics Ltd. $1.86.
Related Searches
Related Searches
Kazia therapeutics limited share price
kazia therapeutics linkedin
kazia therapeutics pipeline
Knowledge Panel
Knowledge Panel

KAZIA THERAPEUTICS LIMITED (Biotechnology company)

kaziatherapeutics.com/

Kazia Therapeutics Limited operates as an biotechnology company. The Company develops anti-cancer drugs, as well as provides pharmaceutical research and development technology solutions. Kazia Therapeutics serves customers globally.

bloomberg.com/profile/company/NRT:AU#:~:text=Kazia%20Therapeutics%20Limited%20operates%20as,Kazia%20Therapeutics%20serves%20customers%20globally.
  • Stock price : KZIA (NASDAQ) $0.23 0.00 (-1.29%)Jun 17, 4:00 PM EDT - Disclaimer
  • Subsidiaries : Glycotex, Inc., Novogen Research Pty Ltd., MORE
  • Headquarters : New South Wales, Australia
  • Date founded : 1994

All information on this page is taken from publicly available sources, and the analysis we provide is a representation of Google's search results for the entity and does not represent any opinion or judgement about the entity by Kalicube itself. If you disagree with this analysis, please contact us and cite this reference : 194140